Author

Sandra Lubitz

Evotec (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Alexandra Hackmann· 1 shared Alice DrobnyiD· 1 shared Bastian ZimmeriD· 1 shared Carina WollnikiD· 1 shared Carsten Jörn BeeseiD· 1 shared Christopher BruhniD· 1 shared Fabrizia Zoppetti· 1 shared Henrik RenneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alexandra Hackmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A human induced pluripotent stem cell-based high-throughput screening platform for teratogenicity hazard identification

Henrik Renner, Kinga Maria Wrona, Christopher Bruhn, Alice Drobny, Rachel McCannon, Fabrizia Zoppetti, Meik Henningsen, Kornelia Kuc, Carsten Jörn Beese, Carina Wollnik, Vladimir Galatenko, Alexandra Hackmann, Sandra Lubitz, Bastian Zimmer

Four-model hiPSC screen in 384-well imaging reached 83% accuracy (88% sensitivity, 75% specificity) on 130 scored compounds from a 146-compound reference set, scalable to hundreds of compounds monthly.

bioRxiv · Oct 30, 2026 · PreprintPharmacology & Toxicology✦ In-depth digest